MedWatch

After several cancellations in 2019, the stock exchange window is open again - analysts are divided over new listings in Denmark

A number of Danish pharmaceutical and medtech companies abandoned their plans to enter the stock exchange in 2019, as the share climate suddenly became unbeneficial. Since then, the feeling in the market has changed, and the window for initial offerings is open again, analysts say. One company has already announced its stock exchange entrance.

Analysts predict good opportunities for Danish life science companies when it comes to entering the Copenhagen stock exchanges. Photo: Finn Frandsen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles